Naperville, IL -- (ReleaseWire) -- 02/24/2014 --Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022 market report to its offering
PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022

Summary

After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this growing pipeline of late-stage drugs, this market is expected to experience substantial growth over the next decade.

Although the prevalence of obesity in the UK is one of the highest among the EU countries, it is a severely underserved market, with Xenical and its generic being the sole therapies for chronic weight management. Due to the high cost of therapy, most patients have been taking generic orlistat. In the UK, overweight and obesity are traditionally treated with lifestyle modifications, such as dietary regulation and increased physical activity.

Scope

- Overview of Obesity including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the UK from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the UK Obesity market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Obesity.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of drug performance.
- Obtain sales forecast for drugs from 2012-2022 in the UK.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/150639/pharmapoint-obesity-uk-drug-forecast-and-market-analysis-to-2022.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###